Tyra Biosciences Q2 EPS $(0.32) Beats $(0.41) Estimate
Portfolio Pulse from Benzinga Newsdesk
Tyra Biosciences (NASDAQ:TYRA) reported a Q2 EPS loss of $(0.32), beating the analyst consensus estimate of $(0.41) by 21.95%. This represents a 3.23% increase in losses compared to the same period last year.
August 07, 2024 | 8:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tyra Biosciences reported a Q2 EPS loss of $(0.32), beating the analyst consensus estimate of $(0.41) by 21.95%. Despite the beat, the loss increased by 3.23% compared to the same period last year.
The better-than-expected EPS loss is likely to have a positive short-term impact on Tyra Biosciences' stock price as it shows the company is performing better than analysts anticipated. However, the year-over-year increase in losses may temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100